Alipay Agent Pay Arrives 🧠 95-Min AI Film Hits Cannes 🎬 Pfizer’s $10.5B China Deal 💊

2026-06-01 | subscribe | homepage

Welcome back to China Insights Weekly. Here are some of the key highlights for this week’s edition:

• European firms deepen China manufacturing, despite de-risking pressure from Brussels

• Huawei reveals LogicFolding, a chip-design workaround for advanced-node limits

• CATL launches truck battery swaps, with 120-second exchanges for urban logistics

• Urban renewal gets a five-year plan, covering homes, pipelines, and old communities

Remember to follow us on LinkedIn, X or Facebook.

🚀 Headlines

European companies double down on China manufacturing despite EU de-risking push (link)

Despite the EU’s de‑risking rhetoric, European companies are deepening their manufacturing ties to China. A survey of nearly 300 members of the EU Chamber of Commerce in China, conducted in early 2026, shows that for the first time in five years, the share of European companies reporting a worsening business environment in China has fallen. Optimism is edging up: 48% saw market access barriers ease (up from 44%), and the proportion citing China’s slowdown as a top challenge dropped 14 points to 57%. Profits remain solid, 70% of firms posted positive pre‑EBIT earnings in 2025, and 75% say their Chinese production is more efficient than anywhere else. Fully 94% view China as an important sourcing destination, citing speed, cost, and reliability. The survey found that 68% of companies are maintaining or expanding their local operations, while only 7% are shifting production elsewhere.

Pfizer and China’s Innovent Biologics signed USD 10.5 billion global agreement to develop cancer drugs (link)

Pfizer has struck a global oncology collaboration with China's Innovent Biologics valued at up to $10.5 billion, underscoring the growing appeal of Chinese biotech innovation to Western pharmaceutical giants. The agreement, announced on May 29th, includes a $650 million upfront payment and up to $9.85 billion in contingent milestones across a portfolio of 12 programmes: eight early-stage assets originated by Innovent and four discovery initiatives proposed by Pfizer. For Innovent, which has already secured licensing deals with Roche, Takeda, and Eli Lilly, the pact validates its R&D pipeline, including the PD-1 inhibitor Tyvyt, approved for eight cancer indications in China. For Pfizer, still integrating its $43 billion acquisition of Seagen and navigating patent cliffs on legacy drugs, the deal represents a cost-efficient strategy to replenish its oncology pipeline through external partnerships rather than outright acquisitions.

Huawei plans new smartphone chips this fall as rivalry with Nvidia and Apple heats up (link)

Huawei has unveiled a chip‑design technique called “LogicFolding” that it will use in its Kirin smartphone chips this autumn. The company claims that by 2031, the approach could match the capabilities of a 1.4‑nanometre manufacturing process, even as TSMC, the world’s leading foundry, has only just begun volume production of 2nm chips. Blocked from buying advanced lithography equipment, Huawei has turned to alternative engineering. Over the past six years, it says it has mass‑produced 381 chips based on its so‑called “τ Scaling Law”. The move represents another attempt to bypass Western sanctions and sustain its rivalry with Apple and Nvidia.

CATL launches China's first standardized light truck battery swap ecosystem (link)

CATL has launched China’s first standardised light‑truck battery‑swap ecosystem, partnering with logistics firm DST. A swap takes just 120 seconds. Over an eight‑year life cycle, energy costs are roughly half those of a diesel truck, saving more than 2,000 hours of refuelling time. The modular stations work with wheelbases from 2.7‑3.75 metres and serve both passenger and commercial vehicles using CATL’s #25 and #35 batteries. So far, 31 stations are operating in the Greater Bay Area; 140 are planned by year‑end. By the end of 2026, CATL and DST will put 5,000 battery‑swap light trucks into service, creating the country’s largest such fleet. The battery‑maker aims for over 3,000 passenger‑vehicle and light‑truck swap stations in 2026, with a long‑term goal of 30,000. The move extends CATL’s lead in electrifying urban logistics.

ByteDance’s Seedance 2.0 hits Cannes with 95-minute AI film Hell Grind (link)

At the Cannes Film Festival, ByteDance’s Seedance 2.0 model powered “Hell Grind”, a 95‑minute feature billed as the world’s first full‑length AI‑generated film. The movie was produced by Higgsfield, a US‑based AI company, using ByteDance’s video‑generation technology. A team of just 15 people completed it in 14 days on a budget of under USD 500,000, a fraction of the tens of millions that a traditional film of similar scale would cost. Most AI video tools still produce clips of only 15 to 30 seconds, making long‑form narrative a major bottleneck. “Hell Grind” suggests that the barrier is falling, shifting filmmaking’s constraints from budget and crew size to creative direction. For independent creators, the economics are revolutionary. Yet it also raises hard questions about authorship, workforce displacement, and what “artistic intent” means when emotion can be optimised by algorithms.